AI assistant
Sending…
Dolby Laboratories, Inc. — Director's Dealing 2021
Mar 3, 2021
30828_dirs_2021-03-03_d7a0af33-94c3-4e80-82ed-7de17a69c36f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2021-03-01
Reporting Person: SHERMAN MARK ANDREW (EVP, GEN. COUN. & SECRTY)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Class A Common Stock | M | 13000 | $45.50 | Acquired | 63010 | Direct |
| 2021-03-01 | Class A Common Stock | S | 13000 | $100.00 | Disposed | 50010 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option (right to buy) | $45.50 | M | 13000 | Disposed | 2026-12-15 | Class A Common Stock (13000) | Direct |
Footnotes
F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest
F2: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
More from Dolby Laboratories, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Feb 6